Signal Transduction and Targeted Therapy-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=890254, encodeId=efe5890254ac, content=初始审核后多久才能被分配审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=中啊, createdTime=Mon Oct 05 18:31:42 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799338, encodeId=c68be9933878, content=能发Cell Death and Differentiation水平的文章投这个杂志合适不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Sun Jun 21 22:44:32 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893695, encodeId=3e988936958f, content=投稿命中率:25.0 经验分享：十天拒稿咯，还是有难度的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Thu Oct 22 10:02:14 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883918, encodeId=e9c888391839, content=送审后，一审被拒的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Sep 09 17:00:24 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1194026, encodeId=a7f6119402697, content=投稿现在显示under consideration有2周了不知道是否送审了，求各位前辈指点～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02255295904, createdName=fuhua.W, createdTime=Wed Feb 16 14:17:07 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=904967, encodeId=5ced90496e9e, content=历时十个月，大修两次，小修一次，终于接收。非常难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVYFEMns6dNLiccqXf6fnmGlWxXmXBLuYJHGHiadibSlmX2NHhVYNj6NMaKGvL0JTrlcfwT22ILNiaiaQ/132, createdBy=fcfe2293917, createdName=moroni, createdTime=Fri Dec 04 20:40:02 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889055, encodeId=476b889055aa, content=为编辑部的效率点赞！文章接收前后沟通特别友善、顺畅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Tue Sep 29 04:24:19 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=)]

2020-10-05 中啊

初始审核后多久才能被分配审稿人啊？

228 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=890254, encodeId=efe5890254ac, content=初始审核后多久才能被分配审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=中啊, createdTime=Mon Oct 05 18:31:42 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799338, encodeId=c68be9933878, content=能发Cell Death and Differentiation水平的文章投这个杂志合适不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Sun Jun 21 22:44:32 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893695, encodeId=3e988936958f, content=投稿命中率:25.0 经验分享：十天拒稿咯，还是有难度的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Thu Oct 22 10:02:14 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883918, encodeId=e9c888391839, content=送审后，一审被拒的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Sep 09 17:00:24 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1194026, encodeId=a7f6119402697, content=投稿现在显示under consideration有2周了不知道是否送审了，求各位前辈指点～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02255295904, createdName=fuhua.W, createdTime=Wed Feb 16 14:17:07 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=904967, encodeId=5ced90496e9e, content=历时十个月，大修两次，小修一次，终于接收。非常难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVYFEMns6dNLiccqXf6fnmGlWxXmXBLuYJHGHiadibSlmX2NHhVYNj6NMaKGvL0JTrlcfwT22ILNiaiaQ/132, createdBy=fcfe2293917, createdName=moroni, createdTime=Fri Dec 04 20:40:02 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889055, encodeId=476b889055aa, content=为编辑部的效率点赞！文章接收前后沟通特别友善、顺畅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Tue Sep 29 04:24:19 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=)]

2020-06-21 尊严

能发Cell Death and Differentiation水平的文章投这个杂志合适不？

208 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=890254, encodeId=efe5890254ac, content=初始审核后多久才能被分配审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=中啊, createdTime=Mon Oct 05 18:31:42 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799338, encodeId=c68be9933878, content=能发Cell Death and Differentiation水平的文章投这个杂志合适不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Sun Jun 21 22:44:32 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893695, encodeId=3e988936958f, content=投稿命中率:25.0 经验分享：十天拒稿咯，还是有难度的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Thu Oct 22 10:02:14 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883918, encodeId=e9c888391839, content=送审后，一审被拒的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Sep 09 17:00:24 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1194026, encodeId=a7f6119402697, content=投稿现在显示under consideration有2周了不知道是否送审了，求各位前辈指点～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02255295904, createdName=fuhua.W, createdTime=Wed Feb 16 14:17:07 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=904967, encodeId=5ced90496e9e, content=历时十个月，大修两次，小修一次，终于接收。非常难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVYFEMns6dNLiccqXf6fnmGlWxXmXBLuYJHGHiadibSlmX2NHhVYNj6NMaKGvL0JTrlcfwT22ILNiaiaQ/132, createdBy=fcfe2293917, createdName=moroni, createdTime=Fri Dec 04 20:40:02 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889055, encodeId=476b889055aa, content=为编辑部的效率点赞！文章接收前后沟通特别友善、顺畅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Tue Sep 29 04:24:19 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=)]

2020-10-22 RoseTiger

投稿命中率:25.0
经验分享：十天拒稿咯，还是有难度的

145 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=890254, encodeId=efe5890254ac, content=初始审核后多久才能被分配审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=中啊, createdTime=Mon Oct 05 18:31:42 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799338, encodeId=c68be9933878, content=能发Cell Death and Differentiation水平的文章投这个杂志合适不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Sun Jun 21 22:44:32 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893695, encodeId=3e988936958f, content=投稿命中率:25.0 经验分享：十天拒稿咯，还是有难度的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Thu Oct 22 10:02:14 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883918, encodeId=e9c888391839, content=送审后，一审被拒的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Sep 09 17:00:24 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1194026, encodeId=a7f6119402697, content=投稿现在显示under consideration有2周了不知道是否送审了，求各位前辈指点～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02255295904, createdName=fuhua.W, createdTime=Wed Feb 16 14:17:07 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=904967, encodeId=5ced90496e9e, content=历时十个月，大修两次，小修一次，终于接收。非常难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVYFEMns6dNLiccqXf6fnmGlWxXmXBLuYJHGHiadibSlmX2NHhVYNj6NMaKGvL0JTrlcfwT22ILNiaiaQ/132, createdBy=fcfe2293917, createdName=moroni, createdTime=Fri Dec 04 20:40:02 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889055, encodeId=476b889055aa, content=为编辑部的效率点赞！文章接收前后沟通特别友善、顺畅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Tue Sep 29 04:24:19 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=)]

2020-09-09 a201061519

送审后，一审被拒的概率大吗？

116 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=890254, encodeId=efe5890254ac, content=初始审核后多久才能被分配审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=中啊, createdTime=Mon Oct 05 18:31:42 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799338, encodeId=c68be9933878, content=能发Cell Death and Differentiation水平的文章投这个杂志合适不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Sun Jun 21 22:44:32 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893695, encodeId=3e988936958f, content=投稿命中率:25.0 经验分享：十天拒稿咯，还是有难度的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Thu Oct 22 10:02:14 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883918, encodeId=e9c888391839, content=送审后，一审被拒的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Sep 09 17:00:24 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1194026, encodeId=a7f6119402697, content=投稿现在显示under consideration有2周了不知道是否送审了，求各位前辈指点～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02255295904, createdName=fuhua.W, createdTime=Wed Feb 16 14:17:07 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=904967, encodeId=5ced90496e9e, content=历时十个月，大修两次，小修一次，终于接收。非常难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVYFEMns6dNLiccqXf6fnmGlWxXmXBLuYJHGHiadibSlmX2NHhVYNj6NMaKGvL0JTrlcfwT22ILNiaiaQ/132, createdBy=fcfe2293917, createdName=moroni, createdTime=Fri Dec 04 20:40:02 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889055, encodeId=476b889055aa, content=为编辑部的效率点赞！文章接收前后沟通特别友善、顺畅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Tue Sep 29 04:24:19 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=)]

2023-04-14 ms6000001495294634 来自天津

偏重的研究方向：肝脏;肠道
经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊

325 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=890254, encodeId=efe5890254ac, content=初始审核后多久才能被分配审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=中啊, createdTime=Mon Oct 05 18:31:42 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799338, encodeId=c68be9933878, content=能发Cell Death and Differentiation水平的文章投这个杂志合适不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Sun Jun 21 22:44:32 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893695, encodeId=3e988936958f, content=投稿命中率:25.0 经验分享：十天拒稿咯，还是有难度的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Thu Oct 22 10:02:14 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883918, encodeId=e9c888391839, content=送审后，一审被拒的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Sep 09 17:00:24 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1194026, encodeId=a7f6119402697, content=投稿现在显示under consideration有2周了不知道是否送审了，求各位前辈指点～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02255295904, createdName=fuhua.W, createdTime=Wed Feb 16 14:17:07 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=904967, encodeId=5ced90496e9e, content=历时十个月，大修两次，小修一次，终于接收。非常难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVYFEMns6dNLiccqXf6fnmGlWxXmXBLuYJHGHiadibSlmX2NHhVYNj6NMaKGvL0JTrlcfwT22ILNiaiaQ/132, createdBy=fcfe2293917, createdName=moroni, createdTime=Fri Dec 04 20:40:02 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889055, encodeId=476b889055aa, content=为编辑部的效率点赞！文章接收前后沟通特别友善、顺畅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Tue Sep 29 04:24:19 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=)]

2022-02-16 fuhua.W

投稿现在显示under consideration有2周了不知道是否送审了，求各位前辈指点～

217 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=890254, encodeId=efe5890254ac, content=初始审核后多久才能被分配审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=中啊, createdTime=Mon Oct 05 18:31:42 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799338, encodeId=c68be9933878, content=能发Cell Death and Differentiation水平的文章投这个杂志合适不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Sun Jun 21 22:44:32 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893695, encodeId=3e988936958f, content=投稿命中率:25.0 经验分享：十天拒稿咯，还是有难度的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Thu Oct 22 10:02:14 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883918, encodeId=e9c888391839, content=送审后，一审被拒的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Sep 09 17:00:24 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1194026, encodeId=a7f6119402697, content=投稿现在显示under consideration有2周了不知道是否送审了，求各位前辈指点～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02255295904, createdName=fuhua.W, createdTime=Wed Feb 16 14:17:07 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=904967, encodeId=5ced90496e9e, content=历时十个月，大修两次，小修一次，终于接收。非常难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVYFEMns6dNLiccqXf6fnmGlWxXmXBLuYJHGHiadibSlmX2NHhVYNj6NMaKGvL0JTrlcfwT22ILNiaiaQ/132, createdBy=fcfe2293917, createdName=moroni, createdTime=Fri Dec 04 20:40:02 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889055, encodeId=476b889055aa, content=为编辑部的效率点赞！文章接收前后沟通特别友善、顺畅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Tue Sep 29 04:24:19 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=)]

2022-12-09 12056e7dm61(暂无昵称) 来自安徽省

请问大家，一修后被拒的可能性有多大？

434 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=890254, encodeId=efe5890254ac, content=初始审核后多久才能被分配审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=中啊, createdTime=Mon Oct 05 18:31:42 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799338, encodeId=c68be9933878, content=能发Cell Death and Differentiation水平的文章投这个杂志合适不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Sun Jun 21 22:44:32 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893695, encodeId=3e988936958f, content=投稿命中率:25.0 经验分享：十天拒稿咯，还是有难度的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Thu Oct 22 10:02:14 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883918, encodeId=e9c888391839, content=送审后，一审被拒的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Sep 09 17:00:24 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1194026, encodeId=a7f6119402697, content=投稿现在显示under consideration有2周了不知道是否送审了，求各位前辈指点～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02255295904, createdName=fuhua.W, createdTime=Wed Feb 16 14:17:07 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=904967, encodeId=5ced90496e9e, content=历时十个月，大修两次，小修一次，终于接收。非常难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVYFEMns6dNLiccqXf6fnmGlWxXmXBLuYJHGHiadibSlmX2NHhVYNj6NMaKGvL0JTrlcfwT22ILNiaiaQ/132, createdBy=fcfe2293917, createdName=moroni, createdTime=Fri Dec 04 20:40:02 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889055, encodeId=476b889055aa, content=为编辑部的效率点赞！文章接收前后沟通特别友善、顺畅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Tue Sep 29 04:24:19 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=)]

2020-12-04 moroni

历时十个月，大修两次，小修一次，终于接收。非常难投。

148 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=890254, encodeId=efe5890254ac, content=初始审核后多久才能被分配审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=中啊, createdTime=Mon Oct 05 18:31:42 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799338, encodeId=c68be9933878, content=能发Cell Death and Differentiation水平的文章投这个杂志合适不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Sun Jun 21 22:44:32 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893695, encodeId=3e988936958f, content=投稿命中率:25.0 经验分享：十天拒稿咯，还是有难度的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Thu Oct 22 10:02:14 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883918, encodeId=e9c888391839, content=送审后，一审被拒的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Sep 09 17:00:24 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1194026, encodeId=a7f6119402697, content=投稿现在显示under consideration有2周了不知道是否送审了，求各位前辈指点～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02255295904, createdName=fuhua.W, createdTime=Wed Feb 16 14:17:07 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=904967, encodeId=5ced90496e9e, content=历时十个月，大修两次，小修一次，终于接收。非常难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVYFEMns6dNLiccqXf6fnmGlWxXmXBLuYJHGHiadibSlmX2NHhVYNj6NMaKGvL0JTrlcfwT22ILNiaiaQ/132, createdBy=fcfe2293917, createdName=moroni, createdTime=Fri Dec 04 20:40:02 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889055, encodeId=476b889055aa, content=为编辑部的效率点赞！文章接收前后沟通特别友善、顺畅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Tue Sep 29 04:24:19 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=)]

2020-09-29 hewty

为编辑部的效率点赞！文章接收前后沟通特别友善、顺畅

133 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=890254, encodeId=efe5890254ac, content=初始审核后多久才能被分配审稿人啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210301/f8c6cedf590b428e995d7418b12fecdf/3ca40bdbedf6430d90d6ada162ebe274.jpg, createdBy=46eb5398335, createdName=中啊, createdTime=Mon Oct 05 18:31:42 CST 2020, time=2020-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799338, encodeId=c68be9933878, content=能发Cell Death and Differentiation水平的文章投这个杂志合适不？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/ba3f7315b20948fe825bf4dddc7209da/51f5ca756fdb4c499362b29a2af5657b.jpg, createdBy=cabf5294282, createdName=尊严, createdTime=Sun Jun 21 22:44:32 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893695, encodeId=3e988936958f, content=投稿命中率:25.0 经验分享：十天拒稿咯，还是有难度的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=145, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26812404059, createdName=RoseTiger, createdTime=Thu Oct 22 10:02:14 CST 2020, time=2020-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=883918, encodeId=e9c888391839, content=送审后，一审被拒的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Sep 09 17:00:24 CST 2020, time=2020-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2125873, encodeId=2d8e21258e302, content=偏重的研究方向：肝脏;肠道 经验分享：已经审稿两个月了，还没有信息，他们大杂志不会身高这么久给拒绝吧！！！！好漫长啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=325, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b5668633584, createdName=ms6000001495294634, createdTime=Fri Apr 14 11:01:47 CST 2023, time=2023-04-14, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1194026, encodeId=a7f6119402697, content=投稿现在显示under consideration有2周了不知道是否送审了，求各位前辈指点～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=217, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02255295904, createdName=fuhua.W, createdTime=Wed Feb 16 14:17:07 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2105100, encodeId=80ef2105100ed, content=请问大家，一修后被拒的可能性有多大？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=434, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed902172873, createdName=12056e7dm61(暂无昵称), createdTime=Fri Dec 09 16:43:03 CST 2022, time=2022-12-09, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=904967, encodeId=5ced90496e9e, content=历时十个月，大修两次，小修一次，终于接收。非常难投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVYFEMns6dNLiccqXf6fnmGlWxXmXBLuYJHGHiadibSlmX2NHhVYNj6NMaKGvL0JTrlcfwT22ILNiaiaQ/132, createdBy=fcfe2293917, createdName=moroni, createdTime=Fri Dec 04 20:40:02 CST 2020, time=2020-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889055, encodeId=476b889055aa, content=为编辑部的效率点赞！文章接收前后沟通特别友善、顺畅, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=638c1675816, createdName=hewty, createdTime=Tue Sep 29 04:24:19 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957146, encodeId=8fff95e1460d, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/d7902bcf52f94c5190172309606f3858/06092b9280764246ad42c419b945d52c.jpg, createdBy=abac5169286, createdName=科研小麻瓜, createdTime=Thu Apr 15 01:54:43 CST 2021, time=2021-04-15, status=1, ipAttribution=)]

2021-04-15 科研小麻瓜

审稿速度:2.0 | 投稿命中率:5.0
经验分享：投的综述，一个月，回来四个审稿人意见，都很认真负责和专业，提出了一些新的观点，看得出是领域专家，也给予了我肯定，只可惜副主编觉得我不太符合综述应该大而全的特点，可能我更适合投minireview，感觉这个期刊很不错，很有前途

454 7

展开7条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务